A randomized controlled trial for the prevention of Japanese cedar pollinosis by Levocetirizine in the pollen exposure chamber
Not Applicable
- Conditions
- cedar pollinosis
- Registration Number
- JPRN-UMIN000006318
- Lead Sponsor
- Department of Otorhinolaryngology in Ciba University Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnant women and those at risk of pregnancy 2)lactating woman 3)Complication of the other nasal-paranasal disease 4)Use of other antiallergic agent 5)Allergia for an ingredient of Levocetirizine 6)severe renal disturbance (creatinine clearance: less than 10mL/min)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total nasal symptom score in Day1 (3hr of pollen exposition).
- Secondary Outcome Measures
Name Time Method 1.A symptom in a chamber in Day1. 2.A symprom after pollen exposition in Day1. 3.Nasal nitric oxide before and after pollen exposition. 4.Safty.